476 results on '"Peter Ott"'
Search Results
2. Diverse roles of the metal binding domains and transport mechanism of copper transporting P-type ATPases
- Author
-
Zongxin Guo, Fredrik Orädd, Viktoria Bågenholm, Christina Grønberg, Jian Feng Ma, Peter Ott, Yong Wang, Magnus Andersson, Per Amstrup Pedersen, Kaituo Wang, and Pontus Gourdon
- Subjects
Science - Abstract
Abstract Copper transporting P-type (P1B-1-) ATPases are essential for cellular homeostasis. Nonetheless, the E1-E1P-E2P-E2 states mechanism of P1B-1-ATPases remains poorly understood. In particular, the role of the intrinsic metal binding domains (MBDs) is enigmatic. Here, four cryo-EM structures and molecular dynamics simulations of a P1B-1-ATPase are combined to reveal that in many eukaryotes the MBD immediately prior to the ATPase core, MBD−1, serves a structural role, remodeling the ion-uptake region. In contrast, the MBD prior to MBD−1, MBD−2, likely assists in copper delivery to the ATPase core. Invariant Tyr, Asn and Ser residues in the transmembrane domain assist in positioning sulfur-providing copper-binding amino acids, allowing for copper uptake, binding and release. As such, our findings unify previously conflicting data on the transport and regulation of P1B-1-ATPases. The results are critical for a fundamental understanding of cellular copper homeostasis and for comprehension of the molecular bases of P1B-1-disorders and ongoing clinical trials.
- Published
- 2024
- Full Text
- View/download PDF
3. Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targets
- Author
-
Peter Ott, Thomas Sandahl, Aftab Ala, David Cassiman, Eduardo Couchonnal-Bedoya, Rubens Gisbert Cury, Anna Czlonkowska, Gerald Denk, Renata D’Inca, Francisco de Assis Aquino Gondim, Joanna Moore, Aurelia Poujois, Carlos Alexandre Twardowschy, Karl Heinz Weiss, Massimo Zuin, C.Omar F. Kamlin, and Michael L. Schilsky
- Subjects
Exchangeable copper ,bioavailable copper ,free serum copper ,protein speciation ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background & Aims: Wilson disease (WD) is caused by accumulation of copper primarily in the liver and brain. During maintenance therapy of WD with D-penicillamine, current guidelines recommend on-treatment ranges of urinary copper excretion (UCE) of 200-500 μg/24 h and serum non-ceruloplasmin-bound copper (NCC) of 50-150 μg/L. We compared NCC (measured by two novel assays) and UCE from patients with clinically stable WD on D-penicillamine therapy with these recommendations. Methods: This is a secondary analysis of data from the Chelate trial (NCT03539952) that enrolled physician-selected patients with clinically stable WD on D-penicillamine maintenance therapy (at an unaltered dose for at least 4 months). We analyzed laboratory samples from the first screening visit, prior to interventions. NCC was measured by either protein speciation (NCC-Sp) using anion exchange high-performance liquid chromatography protein speciation followed by copper determination with inductively coupled plasma mass spectroscopy or as exchangeable copper (NCC-Ex). NCC-Sp was also analyzed in healthy controls (n = 75). Results: In 76 patients with WD with 21.3±14.3 average treatment-years, NCC-Sp (mean±SD: 56.6±26.2 μg/L) and NCC-Ex (mean±SD: 57.9±24.7 μg/L) were within the 50-150 μg/L target in 61% and 54% of patients, respectively. In addition, 36% and 31%, respectively, were even below the normal ranges (NCC-Sp: 46-213 μg/L, NCC-Ex: 41-71 μg/L). NCC-Ex positively correlated with NCC-Sp (r2 = 0.66, p
- Published
- 2024
- Full Text
- View/download PDF
4. Distribution of non-ceruloplasmin-bound copper after i.v. 64Cu injection studied with PET/CT in patients with Wilson disease
- Author
-
Ditte Emilie Munk, Mikkel Holm Vendelbo, Frederik Teicher Kirk, Karina Stubkjær Rewitz, Dirk Andreas Bender, Karina Højrup Vase, Ole Lajord Munk, Hendrik Vilstrup, Peter Ott, and Thomas Damgaard Sandahl
- Subjects
Tracer kinetics ,NCC ,free copper ,whole-body distribution ,bioavailable copper ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background & Aims: In Wilson disease (WD), copper accumulation and increased non-ceruloplasmin-bound copper in plasma lead to liver and brain pathology. To better understand the fate of non-ceruloplasmin-bound copper, we used PET/CT to examine the whole-body distribution of intravenously injected 64-copper (64Cu). Methods: Eight patients with WD, five heterozygotes, and nine healthy controls were examined by dynamic PET/CT for 90 min and static PET/CT up to 20 h after injection. We measured 64Cu activity in blood and tissue and quantified the kinetics by compartmental analysis. Results: Initially, a large fraction of injected 64Cu was distributed to extrahepatic tissues, especially skeletal muscle. Thus, across groups, extrahepatic tissues accounted for 45-58% of the injected dose (%ID) after 10 min, and 45-55% after 1 h. Kinetic analysis showed rapid exchange of 64Cu between blood and muscle as well as adipose tissue, with 64Cu retention in a secondary compartment, possibly mitochondria. This way, muscle and adipose tissue may protect the brain from spikes in non-ceruloplasmin-bound copper. Tiny amounts of cerebral 64Cu were detected (0.2%ID after 90 min and 0.3%ID after 6 h), suggesting tight control of cerebral copper in accordance with a cerebral clearance that is 2-3-fold lower than in muscle. Compared to controls, patients with WD accumulated more hepatic copper 6-20 h after injection, and also renal copper at 6 h. Conclusion: Non-ceruloplasmin-bound copper is initially distributed into a number of tissues before being redistributed slowly to the eliminating organ, the liver. Cerebral uptake of copper is extremely slow and likely highly regulated. Our findings provide new insights into the mechanisms of copper control. Impact and implications: Maintaining non-ceruloplasmin-bound copper within the normal range is an important treatment goal in WD as this “free” copper is considered toxic to the liver and brain. We found that intravenously injected non-ceruloplasmin-bound copper quickly distributed to a number of tissues, especially skeletal muscle, subcutaneous fat, and the liver, while uptake into the brain was slow. This study offers new insights into the mechanisms of copper control, which may encourage further research into potential new treatment targets. Clinical trial number: 2016–001975-59.
- Published
- 2023
- Full Text
- View/download PDF
5. Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study
- Author
-
Ditte Emilie Munk, Tea Lund Laursen, Frederik Teicher Kirk, Hendrik Vilstrup, Aftab Ala, Lars Christian Gormsen, Peter Ott, and Thomas Damgaard Sandahl
- Subjects
Medicine ,Science - Abstract
Abstract Zinc inhibits intestinal copper uptake, an effect utilized for treating Wilson’s disease (WD). We used copper-64 (64Cu) PET/CT to examine how much four weeks of treatment with different zinc regimens reduced the hepatic 64Cu content after oral 64Cu administration and test if alternative regimens were noninferior to the standard regimen of zinc acetate 50 mg × 3 daily. Forty healthy persons were randomized to four different zinc protocols. The WD standard treatment zinc acetate 50 mg × 3 reduced the hepatic 64Cu content from 26.9 ± 7.5% to 13.3 ± 5.6% of the administered 64Cu. Zinc gluconate 50 mg × 3 was noninferior (P = 0.02) (35.8 ± 9.0% to 17.4 ± 7.5%). Zinc acetate 150 mg × 1 (33.1 ± 9.9% to 17.4 ± 7.5%) and zinc gluconate 150 mg × 1 (28.1 ± 6.7% to 22.0 ± 6.7%) were less effective. These effects were intra- and inter-individually highly variable, and 14% had no effect of any zinc regimen, which may explain disparities in zinc treatment efficacy in WD patients.
- Published
- 2022
- Full Text
- View/download PDF
6. Case report: Huppke–Brendel syndrome in an adult, mistaken for and treated as Wilson disease for 25 years
- Author
-
Frederik Teicher Kirk, Ditte Emilie Munk, Jakob Ek, Lisbeth Birk Møller, Mette Bendixen Thorup, Erik Hvid Danielsen, Hendrik Vilstrup, Peter Ott, and Thomas Damgaard Sandahl
- Subjects
Wilson disease ,copper ,neurology ,SLC33A1 ,rare disease ,Huppke-Brendel syndrome ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
BackgroundHuppke–Brendel (HB) syndrome is an autosomal recessive disease caused by variants in the SLC33A1 gene. Since 2012, less than ten patients have been reported, none survived year six. With neurologic involvement and ceruloplasmin deficiency, it may mimic Wilson disease (WD).Objectives and methodsWe report the first adult patient with HB.ResultsThe patient suffered from moderate intellectual disability, partial hearing loss, spastic ataxia, hypotonia, and unilateral tremor of parkinsonian type. At age 29, she was diagnosed with WD based on neurology, elevated 24H urinary copper, low ceruloplasmin, and pathological 65Cu test. Approximately 25 years later, genetic testing did not support WD or aceruloplasminemia. Full genome sequencing revealed two likely pathogenic variants in SLC33A1 which combined with re-evaluation of neurologic symptoms and MRI suggested the diagnosis of HB.ConclusionAdult patients with HB exist and may be confused with WD. Low ceruloplasmin and the absence of ATP7B variants should raise suspicion.
- Published
- 2022
- Full Text
- View/download PDF
7. Multi-Modal Cross Learning for an FMCW Radar Assisted by Thermal and RGB Cameras to Monitor Gestures and Cooking Processes
- Author
-
Marco Altmann, Peter Ott, Nicolaj C. Stache, and Christian Waldschmidt
- Subjects
Machine learning ,neural networks ,radar applications ,multimodal sensors ,cross learning ,autoencoder ,Electrical engineering. Electronics. Nuclear engineering ,TK1-9971 - Abstract
This paper proposes a multi-modal cross learning approach to augment the neural network training phase by additional sensor data. The approach is multi-modal during training (i.e., radar Range-Doppler maps, thermal camera images, and RGB camera images are used for training). In inference, the approach is single-modal (i.e., only radar Range-Doppler maps are needed for classification). The proposed approach uses a multi-modal autoencoder training which creates a compressed data representation containing correlated features across modalities. The encoder part is then used as a pretrained network for the classification task. The benefits are that expensive sensors like high resolution thermal cameras are not needed in the application but a higher classification accuracy is achieved because of the multi-modal cross learning during training. The autoencoders can also be used to generate hallucinated data of the absent sensors. The hallucinated data can be used for user interfaces, a further classification, or other tasks. The proposed approach is verified within a simultaneous cooking process classification, 2 × 2 cooktop occupancy detection, and gesture recognition task. The main functionality is an overboil protection and gesture control of a 2 × 2 cooktop. The multi-modal cross learning approach considerably outperforms single-modal approaches on that challenging classification task.
- Published
- 2021
- Full Text
- View/download PDF
8. The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson’s disease
- Author
-
Emilie Glavind, Daniel N. Gotthardt, Jan Pfeiffenberger, Thomas Damgaard Sandahl, Teodora Bashlekova, Gro Linno Willemoe, Jane Preuss Hasselby, Karl Heinz Weiss, Holger Jon Møller, Hendrik Vilstrup, William M. Lee, Michael L. Schilsky, Peter Ott, and Henning Grønbæk
- Subjects
Wilson’s disease ,Macrophage activation ,Liver cirrhosis ,Acute liver failure ,Biomarker ,Medicine - Abstract
Abstract Background Macrophages play a significant role in liver disease development and progression. The macrophage activation marker soluble (s)CD163 is associated with severity and prognosis in a number of different acute and chronic liver diseases but has been only sparsely examined in Wilson’s disease (WD). We investigated sCD163 levels in patients with acute and chronic WD and hypothesized associations with liver disease phenotype and biochemical markers of liver injury. Methods We investigated sCD163 in two independent cohorts of WD patients: 28 patients with fulminant WD from the US Acute Liver Failure (ALF) Study Group registry and 147 patients with chronic disease from a German WD registry. We included a control group of 19 healthy individuals. Serum sCD163 levels were measured by ELISA. Liver CD163 expression was determined by immunohistochemistry. Results In the ALF cohort, median sCD163 was 10-fold higher than in healthy controls (14.6(2.5–30.9) vs. 1.5(1.0–2.7) mg/L, p
- Published
- 2020
- Full Text
- View/download PDF
9. Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [64Cu]copper PET/CT
- Author
-
Kristoffer Kjærgaard, Thomas Damgaard Sandahl, Kim Frisch, Karina Højrup Vase, Susanne Keiding, Hendrik Vilstrup, Peter Ott, Lars Christian Gormsen, and Ole Lajord Munk
- Subjects
64Cu ,Copper ,Kinetics ,Dosimetry ,Biodistribution ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Abstract Purpose Copper is essential for enzymatic processes throughout the body. [64Cu]copper (64Cu) positron emission tomography (PET) has been investigated as a diagnostic tool for certain malignancies, but has not yet been used to study copper homeostasis in humans. In this study, we determined the hepatic removal kinetics, biodistribution and radiation dosimetry of 64Cu in healthy humans by both intravenous and oral administration. Methods Six healthy participants underwent PET/CT studies with intravenous or oral administration of 64Cu. A 90 min dynamic PET/CT scan of the liver was followed by three whole-body PET/CT scans at 1.5, 6, and 20 h after tracer administration. PET data were used for estimation of hepatic kinetics, biodistribution, effective doses, and absorbed doses for critical organs. Results After intravenous administration, 64Cu uptake was highest in the liver, intestinal walls and pancreas; the gender-averaged effective dose was 62 ± 5 μSv/MBq (mean ± SD). After oral administration, 64Cu was almost exclusively taken up by the liver while leaving a significant amount of radiotracer in the gastrointestinal lumen, resulting in an effective dose of 113 ± 1 μSv/MBq. Excretion of 64Cu in urine and faeces after intravenous administration was negligible. Hepatic removal kinetics showed that the clearance of 64Cu from blood was 0.10 ± 0.02 mL blood/min/mL liver tissue, and the rate constant for excretion into bile or blood was 0.003 ± 0.002 min− 1. Conclusion 64Cu biodistribution and radiation dosimetry are influenced by the manner of tracer administration with high uptake by the liver, intestinal walls, and pancreas after intravenous administration, while after oral administration, 64Cu is rapidly absorbed from the gastrointestinal tract and deposited primarily in the liver. Administration of 50 MBq 64Cu yielded images of high quality for both administration forms with radiation doses of approximately 3.1 and 5.7 mSv, respectively, allowing for sequential studies in humans. Trial registration number EudraCT no. 2016–001975-59. Registration date: 19/09/2016.
- Published
- 2020
- Full Text
- View/download PDF
10. Hepatic bile acid transport increases in the postprandial state: A functional 11C-CSar PET/CT study in healthy humans
- Author
-
Nikolaj W. Ørntoft, Lars C. Gormsen, Susanne Keiding, Ole L. Munk, Peter Ott, and Michael Sørensen
- Subjects
Hepatobiliary kinetics ,Positron emission tomography ,Liver physiology ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background & Aims: It is not known how hepatic bile acids transport kinetics changes postprandially in the intact liver. We used positron emission tomography (PET)/computed tomography (CT) with the tracer [N-methyl-11C]cholylsarcosine (11C-CSar), a synthetic sarcosine conjugate of cholic acid, to quantify fasting and postprandial hepatic bile acid transport kinetics in healthy human participants. Methods: Six healthy human participants underwent dynamic liver 11C-CSar PET/CT (60 min) during fasting and from 15 min after ingestion of a standard liquid meal. Hepatobiliary secretion kinetics of 11C-CSar was calculated from PET data, blood samples (arterial and hepatic venous) and hepatic blood flow measured using indocyanine green infusion. Results: In the postprandial state, hepatic blood perfusion increased on average by 30% (p
- Published
- 2021
- Full Text
- View/download PDF
11. Glutamate Dehydrogenase Is Important for Ammonia Fixation and Amino Acid Homeostasis in Brain During Hyperammonemia
- Author
-
Caroline M. Voss, Lene Arildsen, Jakob D. Nissen, Helle S. Waagepetersen, Arne Schousboe, Pierre Maechler, Peter Ott, Hendrik Vilstrup, and Anne B. Walls
- Subjects
glutamate dehydogenase ,brain ,hyperammonemia ,glutamate ,alanine ,pyruvate carboxylase (PC) ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Impaired liver function may lead to hyperammonemia and risk for hepatic encephalopathy. In brain, detoxification of ammonia is mediated mainly by glutamine synthetase (GS) in astrocytes. This requires a continuous de novo synthesis of glutamate, likely involving the action of both pyruvate carboxylase (PC) and glutamate dehydrogenase (GDH). An increased PC activity upon ammonia exposure and the importance of PC activity for glutamine synthesis has previously been demonstrated while the importance of GDH for generation of glutamate as precursor for glutamine synthesis has received little attention. We therefore investigated the functional importance of GDH for brain metabolism during hyperammonemia. To this end, brain slices were acutely isolated from transgenic CNS-specific GDH null or litter mate control mice and incubated in aCSF containing [U-13C]glucose in the absence or presence of 1 or 5 mM ammonia. In another set of experiments, brain slices were incubated in aCSF containing 1 or 5 mM 15N-labeled NH4Cl and 5 mM unlabeled glucose. Tissue extracts were analyzed for isotopic labeling in metabolites and for total amounts of amino acids. As a novel finding, we reveal a central importance of GDH function for cerebral ammonia fixation and as a prerequisite for de novo synthesis of glutamate and glutamine during hyperammonemia. Moreover, we demonstrated an important role of the concerted action of GDH and alanine aminotransferase in hyperammonemia; the products alanine and α-ketoglutarate serve as an ammonia sink and as a substrate for ammonia fixation via GDH, respectively. The role of this mechanism in human hyperammonemic states remains to be studied.
- Published
- 2021
- Full Text
- View/download PDF
12. High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study
- Author
-
Jessica Björklund, Tea Lund Laursen, Thomas Damgaard Sandahl, Holger Jon Møller, Hendrik Vilstrup, Peter Ott, and Henning Grønbæk
- Subjects
Wilson disease ,Macrophages ,Liver ,Metabolic liver function ,sCD163 ,Medicine - Abstract
Abstract Background Hepatic macrophage (Kupffer cell) hyperplasia is often described in Wilson’s disease (WD). In many liver diseases, Kupffer cell activation is related to disease severity, liver function, and fibrosis but the importance in WD is unknown. Kupffer cell activation can be assessed by the P-concentration of soluble (s)CD163, metabolic liver function by the galactose elimination capacity (GEC), and fibrosis by Fibroscan. We investigated the associations between sCD163, selected inflammatory cytokines, GEC, and liver fibrosis in Danish WD patients. Methods In a cross-sectional design, we studied 29 stable and well-treated patients (male/female15/14) with a median age of 35 years (IQR 24–50). P-sCD163 and cytokines were measured by ELISA. The GEC was measured by intra-venous galactose loading. Results The median P-sCD163 value at 2.96 mg/L (1.97–3.93) was high in the normal range (0.7–3.9) and seven patients (24%) had a value above the upper normal value. sCD163 correlated with TNF-α, IL-6 and IL-8 (rho> 0.50, p
- Published
- 2018
- Full Text
- View/download PDF
13. On the development of sleep states in the first weeks of life.
- Author
-
Tomasz Wielek, Renata Del Giudice, Adelheid Lang, Malgorzata Wislowska, Peter Ott, and Manuel Schabus
- Subjects
Medicine ,Science - Abstract
Human newborns spend up to 18 hours sleeping. The organization of their sleep differs immensely from adult sleep, and its quick maturation and fundamental changes correspond to the rapid cortical development at this age. Manual sleep classification is specifically challenging in this population given major body movements and frequent shifts between vigilance states; in addition various staging criteria co-exist. In the present study we utilized a machine learning approach and investigated how EEG complexity and sleep stages evolve during the very first weeks of life. We analyzed 42 full-term infants which were recorded twice (at week two and five after birth) with full polysomnography. For sleep classification EEG signal complexity was estimated using multi-scale permutation entropy and fed into a machine learning classifier. Interestingly the baby's brain signal complexity (and spectral power) revealed developmental changes in sleep in the first 5 weeks of life, and were restricted to NREM ("quiet") and REM ("active sleep") states with little to no changes in state wake. Data demonstrate that our classifier performs well over chance (i.e., >33% for 3-class classification) and reaches almost human scoring accuracy (60% at week-2, 73% at week-5). Altogether, these results demonstrate that characteristics of newborn sleep develop rapidly in the first weeks of life and can be efficiently identified by means of machine learning techniques.
- Published
- 2019
- Full Text
- View/download PDF
14. Memory Traces Formed in Utero—Newborns’ Autonomic and Neuronal Responses to Prenatal Stimuli and the Maternal Voice
- Author
-
Adelheid Lang, Peter Ott, Renata del Giudice, and Manuel Schabus
- Subjects
perinatal memory ,fetal learning ,fetus ,newborn ,maternal voice ,heart rate ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
In our pilot study, we exposed third-trimester fetuses, from week 34 of gestation onwards, twice daily to a maternal spoken nursery rhyme. Two and five weeks after birth, 34 newborns, who were either familiarized with rhyme stimulation in utero or stimulation naïve, were (re-)exposed to the familiar, as well as to a novel and unfamiliar, rhyme, both spoken with the maternal and an unfamiliar female voice. For the stimulation-naïve group, both rhymes were unfamiliar. During stimulus presentation, heart rate activity and high-density electroencephalography were collected and newborns’ responses during familiar and unfamiliar stimulation were analyzed. All newborns demonstrated stronger speech–brain coupling at 1 Hz during the presentation of the maternal voice vs. the unfamiliar female voice. Rhyme familiarity originating from prenatal exposure had no effect on speech–brain coupling in experimentally stimulated newborns. Furthermore, only stimulation-naïve newborns demonstrated an increase in heart rate during the presentation of the unfamiliar female voice. The results indicate prenatal familiarization to auditory speech and point to the specific significance of the maternal voice already in two- to five-week-old newborns.
- Published
- 2020
- Full Text
- View/download PDF
15. Sleep in patients with disorders of consciousness characterized by means of machine learning.
- Author
-
Tomasz Wielek, Julia Lechinger, Malgorzata Wislowska, Christine Blume, Peter Ott, Stefan Wegenkittl, Renata Del Giudice, Dominik P J Heib, Helmut A Mayer, Steven Laureys, Gerald Pichler, and Manuel Schabus
- Subjects
Medicine ,Science - Abstract
Sleep has been proposed to indicate preserved residual brain functioning in patients suffering from disorders of consciousness (DOC) after awakening from coma. However, a reliable characterization of sleep patterns in this clinical population continues to be challenging given severely altered brain oscillations, frequent and extended artifacts in clinical recordings and the absence of established staging criteria. In the present study, we try to address these issues and investigate the usefulness of a multivariate machine learning technique based on permutation entropy, a complexity measure. Specifically, we used long-term polysomnography (PSG), along with video recordings in day and night periods in a sample of 23 DOC; 12 patients were diagnosed as Unresponsive Wakefulness Syndrome (UWS) and 11 were diagnosed as Minimally Conscious State (MCS). Eight hour PSG recordings of healthy sleepers (N = 26) were additionally used for training and setting parameters of supervised and unsupervised model, respectively. In DOC, the supervised classification (wake, N1, N2, N3 or REM) was validated using simultaneous videos which identified periods with prolonged eye opening or eye closure.The supervised classification revealed that out of the 23 subjects, 11 patients (5 MCS and 6 UWS) yielded highly accurate classification with an average F1-score of 0.87 representing high overlap between the classifier predicting sleep (i.e. one of the 4 sleep stages) and closed eyes. Furthermore, the unsupervised approach revealed a more complex pattern of sleep-wake stages during the night period in the MCS group, as evidenced by the presence of several distinct clusters. In contrast, in UWS patients no such clustering was found. Altogether, we present a novel data-driven method, based on machine learning that can be used to gain new and unambiguous insights into sleep organization and residual brain functioning of patients with DOC.
- Published
- 2018
- Full Text
- View/download PDF
16. Mechanisms of Control Authority by Nanosecond Pulsed Dielectric Barrier Discharge Actuators on Flow Separation
- Author
-
Christoforos Skourides, Dimitrios Nyfantis, Pénélope Leyland, Hugo Bosse, and Peter Ott
- Subjects
active flow control ,NS-pulse dielectric barrier discharge plasma actuation ,flow-plasma frequency optimisation ,Technology ,Engineering (General). Civil engineering (General) ,TA1-2040 ,Biology (General) ,QH301-705.5 ,Physics ,QC1-999 ,Chemistry ,QD1-999 - Abstract
The mechanisms that should be considered for separation flow control applications of nanosecond pulsed dielectric barrier discharge (DBD) actuators were investigated on a NACA 0015 profile for velocities of 10 m / s ( R e = 100,000 ) and 20 m / s ( R e = 200,000 ) in ambient wind tunnel conditions. Near and post-stall angles of attack were considered ( 16 ∘ and 24 ∘ ). The dominant frequencies existing in the flow were measured. Moderate voltage levels were applied (4 and 7 kV ) and the actuator was operated at these identified dominant frequencies and compared with known effective frequencies from literature. In all cases, influences by the actuator on the flow structures were observed and the operation of the actuator at the dominant flow frequencies of a stalled airfoil was shown to give control authority.
- Published
- 2019
- Full Text
- View/download PDF
17. CFAR Detector for Compressed Sensing Radar Based on l1-norm Minimisation.
- Author
-
Dmitrii Kozlov and Peter Ott
- Published
- 2020
- Full Text
- View/download PDF
18. Cloud architecture for industrial image processing: Platform for realtime inline quality assurance.
- Author
-
Dirk Jacobsen and Peter Ott
- Published
- 2017
- Full Text
- View/download PDF
19. Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantation
- Author
-
Matilde B. Ørum, Frederikke F. Rönsholt, Majbritt Jeppesen, Elisabeth Bendstrup, Terese L. Katzenstein, Peter Ott, Michael Perch, Tacjana Pressler, Tavs Qvist, and Søren Jensen‐Fangel
- Subjects
CFTR therapy ,cystic fibrosis ,Pulmonary and Respiratory Medicine ,ETI ,Pediatrics, Perinatology and Child Health ,cystic fibrosis transmembrane conductance regulator therapy ,solid organ transplantation - Abstract
We report a case series of four patients with cystic fibrosis (CF) and previous solid organ transplantation (SOT) receiving elexacaftor/tezacaftor/ivacaftor therapy for 6 months or more. Data was collected retrospectively. The treatment was well tolerated and all patients reported subjective improvements.
- Published
- 2022
20. Clearance and production of ammonia quantified in humans by constant ammonia infusion - the effects of cirrhosis and ammonia targeting treatments
- Author
-
Peter Lykke Eriksen, Lars Djernes, Hendrik Vilstrup, and Peter Ott
- Subjects
Hepatology - Abstract
BACKGROUND & AIMS: Hyperammonaemia is a key pathological feature of liver disease and the primary driver of hepatic encephalopathy (HE). However, the relative roles of increased ammonia production and reduced clearance are poorly understood as is the action of ammonia-targeting HE drugs. We aimed to quantify whole-body ammonia metabolism in healthy persons and patients with cirrhosis and to validate our method by examining the effects of glycerol phenylbutyrate and lactulose + rifaximin treatment.METHODS: Ten healthy men and ten male patients with cirrhosis were investigated by 90-minute constant ammonia infusion to achieve steady-state plasma ammonia. Whole-body ammonia clearance was calculated as infusion rate divided by steady-state concentration increase and ammonia production as clearance times baseline ammonia concentration. Participants were re-investigated after the ammonia targeting interventions.RESULTS: In healthy persons, ammonia clearance was 3.5 (3.1-3.9) L/min and production 49 (35-63) μmol/min. Phenylbutyrate increased clearance by 11% (4-19%, p=0.009). Patients with cirrhosis had a 20% decreased ammonia clearance of 2.7 (2.1-3.3) L/min (p = 0.02) and a nearly tripled production to 131 (102-159) μmol/min (pCONCLUSIONS: Whole-body ammonia clearance and production may be measured separately by the technique used. The method identified a lower clearance and a higher production in patients with cirrhosis, and showed that phenylbutyrate increases clearance, whereas lactulose + rifaximin reduces production. The method may be used to examine a range of questions related to normo-/pathophysiology and ammonia-targeting treatment mechanisms.IMPACT AND IMPLICATIONS: High blood ammonia plays a key role in liver cirrhosis related brain dysfunction. However, the relative roles of increased ammonia production and reduced ammonia clearance are poorly understood as is the action of ammonia-targeting treatments. This study presents a relatively simple test to measure ammonia metabolism. By use of this test, it was possible to show that patients with liver cirrhosis have decreased ammonia clearance and increased ammonia production compared with healthy persons and to quantify distinctively different ammonia-targeting treatment effects. The test presented holds several perspectives for future studies of normal physiology and pathophysiology, not least in regard to elucidating effects of ammonia-targeting therapies.CLINICAL TRIAL NUMBER: ClinicalTrials.gov (1-16-02-297-20).
- Published
- 2023
21. The pathophysiology of Wilson’s disease visualized: A human 64Cu PET study
- Author
-
Ditte Emilie Munk, Lars C. Gormsen, Susanne Keiding, Ole Lajord Munk, Karina H. Vase, Hendrik Vilstrup, Thomas Damgaard Sandahl, Kim Frisch, Peter Ott, Dirk Bender, Mikkel H. Vendelbo, and Kristoffer Kjærgaard
- Subjects
Heterozygote ,LIVER ,Future studies ,COPPER-METABOLISM ,Hepatolenticular Degeneration/diagnostic imaging ,Post injection ,DIAGNOSIS ,Positron Emission Tomography Computed Tomography ,Humans ,Medicine ,In patient ,(CUCL2)-CU-64 PET/CT ,Hepatology ,medicine.diagnostic_test ,business.industry ,Heterozygote advantage ,MOUSE MODEL ,Pet imaging ,RADIOCOPPER ,Control subjects ,Pathophysiology ,Positron emission tomography ,Positron-Emission Tomography ,EXPERIENCE ,business ,Nuclear medicine - Abstract
BACKGROUND & AIMS: Wilson disease (WD) is a genetic disease with systemic accumulation of copper that leads to symptoms from the liver and brain. However, the underlying defects in copper transport kinetics are only partly understood. We sought to quantify hepatic copper turnover in patients with WD compared with heterozygote and control subjects using positron emission tomography (PET) with copper-64 (64 Cu) as tracer. Furthermore, we assessed the diagnostic potential of the method.METHODS: Nine patients with WD, five healthy heterozygote subjects, and eight healthy controls were injected with an intravenous bolus of 64 Cu followed by a 90-min dynamic PET scan of the liver and static whole-body PET/CT scans after 1.5, 6, and 20 hours. Blood 64 Cu concentrations were measured in parallel. The hepatic copper retention and redistribution were evaluated by standardized uptake values (SUV).RESULTS: At 90 min, the hepatic SUVs were similar in the three groups. In contrast, at 20 hours post injection, the SUV in WD patient (Mean±SEM 31±4) was higher than in heterozygotes (24±3) or controls (21±4), (p < 0.001). An SUV-ratio of the hepatic 64 Cu concentration at 20 and 1.5 hours completely discriminated between the WD patients and control groups (p < 0.0001; ANOVA). By Patlak-analysis of the initial 90 min of the PET scan, the steady-state hepatic clearance of 64 Cu was estimated to be slightly lower in the patients with WD than in controls, (p = 0.04).CONCLUSIONS: 64 Cu PET imaging enables visualisation and quantification of the hepatic copper retention characteristic for WD patients. This method represents a valuable tool for future studies of WD pathophysiology, which may assist the development of novel therapies, and accurate diagnosis.
- Published
- 2022
22. 7 HISTORIOGRAFIEN DES KINOS
- Author
-
Ute Holl and Peter Ott
- Published
- 2022
23. Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE):a randomised, open-label, non-inferiority, phase 3 trial
- Author
-
Michael L Schilsky, Anna Czlonkowska, Massimo Zuin, David Cassiman, Carlos Twardowschy, Aurelia Poujois, Francisco de Assis A Gondim, Gerald Denk, Rubens G Cury, Peter Ott, Joanna Moore, Aftab Ala, Renata D'Inca, Eduardo Couchonnal-Bedoya, Koenraad D'Hollander, Nicolas Dubois, C Omar F Kamlin, Karl Heinz Weiss, Uyen To, Amar Patel, Daksshi Hettiarachchi, Alessia Giorgini, Sara Monico, Tomasz Litwin, Agnieszka Piechal, Marta Skowronska, Alain Lachaux, Abdelouahed Belmalih, Alexandra Boogers, Isabelle Mohr, Andrea Langel, Christian Freitas, Egberto Reis Barbosa, Thomas D Sandahl, Lisbet Gerdes, Alexandre Obadia, Djamila Rahli, and Jeremy Cosgrove
- Subjects
Adult ,Hepatology ,Hepatolenticular Degeneration ,Penicillamine ,Gastroenterology ,Humans ,Trientine ,Copper ,Chelating Agents - Abstract
Background: Wilson disease is an inherited disorder of copper transport. Whereas penicillamine is used therapeutically to re-establish copper balance, trientine is indicated for patients with penicillamine intolerance. We aimed to compare penicillamine with trientine tetrahydrochloride (TETA4) for maintenance therapy in patients with Wilson disease. Methods: We conducted a randomised, open-label, non-inferiority, phase 3 trial at 15 health-care centres across nine countries (patients were recruited from 13 of these health-care centres across Brazil, Europe, and the USA). We enrolled patients aged 18–75 years with stable Wilson disease who were treated for at least 1 year with penicillamine. Patients entered a 12-week period to determine stability through clinical assessment by site investigators and predefined thresholds for serum non-caeruloplasmin-bound copper (NCC; by an exchangeable copper assay; 25–150 μg/L), 24 h urinary copper excretion (100–900 μg/24 h), and alanine aminotransferase (ALT
- Published
- 2022
24. O01 Efficacy and safety of ALXN1840 versus standard of care in Wilson disease: primary results from an ongoing phase 3, randomized, controlled, rater-blinded trial
- Author
-
Karl Heinz Weiss, Michael Schilsky, Anna Czlonkowska, Frederick Askari, Aftab Ala, Peter Ferenci, Peter Ott, Dzhamal Abdurakhmanov, Ferenc Szalay, Piotr Socha, Norikazu Shimizu, Jeff Bronstein, Danny Bega, Sihoun Hahn, Eugene Scott Swenson, Yi Chen, and Aurelia Poujois
- Published
- 2022
25. Effect of oral zinc regimens on human hepatic copper content:a randomized intervention study
- Author
-
Ditte Emilie Munk, Tea Lund Laursen, Frederik Teicher Kirk, Hendrik Vilstrup, Aftab Ala, Lars Christian Gormsen, Peter Ott, and Thomas Damgaard Sandahl
- Subjects
Zinc ,Multidisciplinary ,Hepatolenticular Degeneration ,Positron Emission Tomography Computed Tomography ,Hepatolenticular Degeneration/drug therapy ,Zinc Acetate ,Humans - Abstract
Zinc inhibits intestinal copper uptake, an effect utilized for treating Wilson’s disease (WD). We used copper-64 (64Cu) PET/CT to examine how much four weeks of treatment with different zinc regimens reduced the hepatic 64Cu content after oral 64Cu administration and test if alternative regimens were noninferior to the standard regimen of zinc acetate 50 mg × 3 daily. Forty healthy persons were randomized to four different zinc protocols. The WD standard treatment zinc acetate 50 mg × 3 reduced the hepatic 64Cu content from 26.9 ± 7.5% to 13.3 ± 5.6% of the administered 64Cu. Zinc gluconate 50 mg × 3 was noninferior (P = 0.02) (35.8 ± 9.0% to 17.4 ± 7.5%). Zinc acetate 150 mg × 1 (33.1 ± 9.9% to 17.4 ± 7.5%) and zinc gluconate 150 mg × 1 (28.1 ± 6.7% to 22.0 ± 6.7%) were less effective. These effects were intra- and inter-individually highly variable, and 14% had no effect of any zinc regimen, which may explain disparities in zinc treatment efficacy in WD patients.
- Published
- 2022
26. Multi-Modal Cross Learning for an FMCW Radar Assisted by Thermal and RGB Cameras to Monitor Gestures and Cooking Processes
- Author
-
Peter Ott, Marco Altmann, Christian Waldschmidt, and Nicolaj C. Stache
- Subjects
0209 industrial biotechnology ,General Computer Science ,Computer science ,multimodal sensors ,02 engineering and technology ,law.invention ,020901 industrial engineering & automation ,law ,cross learning ,Radar imaging ,Machine learning ,0202 electrical engineering, electronic engineering, information engineering ,General Materials Science ,Computer vision ,Radar ,autoencoder ,Artificial neural network ,business.industry ,General Engineering ,radar applications ,neural networks ,Autoencoder ,Continuous-wave radar ,Hallucinating ,Gesture recognition ,020201 artificial intelligence & image processing ,Artificial intelligence ,lcsh:Electrical engineering. Electronics. Nuclear engineering ,business ,lcsh:TK1-9971 - Abstract
This paper proposes a multi-modal cross learning approach to augment the neural network training phase by additional sensor data. The approach is multi-modal during training (i.e., radar Range-Doppler maps, thermal camera images, and RGB camera images are used for training). In inference, the approach is single-modal (i.e., only radar Range-Doppler maps are needed for classification). The proposed approach uses a multi-modal autoencoder training which creates a compressed data representation containing correlated features across modalities. The encoder part is then used as a pretrained network for the classification task. The benefits are that expensive sensors like high resolution thermal cameras are not needed in the application but a higher classification accuracy is achieved because of the multi-modal cross learning during training. The autoencoders can also be used to generate hallucinated data of the absent sensors. The hallucinated data can be used for user interfaces, a further classification, or other tasks. The proposed approach is verified within a simultaneous cooking process classification, $2\times 2$ cooktop occupancy detection, and gesture recognition task. The main functionality is an overboil protection and gesture control of a $2\times 2$ cooktop. The multi-modal cross learning approach considerably outperforms single-modal approaches on that challenging classification task.
- Published
- 2021
27. Skalierbare Smart-Kameras für die Inline-Inspektion
- Author
-
Peter Ott, Dirk Jacobsen, Carsten Wittenberg, and Carsten Lanquillon
- Subjects
Physics ,Electrical and Electronic Engineering ,Humanities ,Atomic and Molecular Physics, and Optics - Abstract
Smart-Kameras sind ein elementarer Bestandteil in der industriellen Fertigung. Jedoch veraltet deren Datenverarbeitungshardware schnell, während die Optik langlebig ist. Um Bildanalysealgorithmen mit erhöhtem Ressourcenbedarf trotz Limitierung der Smart-Kamera in Fertigungsanlagen flexibel integrieren zu können, werden in diesem Beitrag die Möglichkeiten diskutiert, wie solche Systeme mit Ressourcen in der Cloud erweiterbar sind. Es wird eine Systemarchitektur und deren Umsetzung vorgestellt, die konstante, wie auch schwankende Bildverarbeitungskapazitäten in der Cloud skalierbar erschließen.
- Published
- 2020
28. The galactose elimination capacity test to monitor liver disease course in patients with Wilson's disease
- Author
-
Ditte Emilie Munk, Jessica Björklund, Tea Lund Laursen, Hendrik Vilstrup, Peter Ott, Henning Grønbæk, and Thomas Damgaard Sandahl
- Subjects
Liver Cirrhosis ,Wilson’s disease ,galactose ,CLINICAL PRESENTATION ,Gastroenterology ,Galactose ,CHILDREN ,DIAGNOSIS ,Hepatolenticular Degeneration/diagnosis ,disease progression ,disease management ,Hepatolenticular Degeneration ,Liver Function Tests ,SCORE ,Galactose/metabolism ,FIBROSIS ,Humans ,liver function test ,Wilson's disease - Abstract
Background: The prognosis of Wilson’s disease (WD) has changed radically since the introduction of medical therapy with chelators and zinc. However, there is an unmet need for methods to evaluate the long-term treatment response and the liver disease progression in order to identify treatment failures. The galactose elimination capacity test (GEC) is a physiological measure of the total metabolic capacity of the liver, and a strong predictor of long- and short-term mortality in patients with liver cirrhosis. Our aim was to investigate if the GEC test is useful for evaluation of treatment response and prediction of treatment failures in WD patients. Methods: We included all patients with WD in Denmark from 1992 through 2017 and retrieved data on GEC along with data on transplantation and death. Results: In total, 37 patients had completed one or more GEC tests. Of these, 31 were alive (three transplanted) and six were dead (two transplanted). A total of 24 patients had completed more than one GEC test. All 18 alive, nontransplanted patients showed improvement in GEC values following onset of treatment, except one patient, who was clinically confirmed with treatment failure. All six patients who underwent liver transplantation or died had a prior decline in their GEC. The difference in GEC development between patients alive and not transplanted and patients dead or transplanted was significant (p
- Published
- 2022
29. Clinical utility of non-ceruloplasmin copper determined by copper speciation for monitoring Wilson disease therapy: comparative data analysis with 24-hour urinary copper excretion from the CHELATE trial
- Author
-
Michael Schilsky, Aurelia Poujois, Massimo Giovanni Zuin, Peter Ott, Karl Heinz Weiss, David Cassiman, Aftab Ala, Anna Czlonkowska, Nicolas Dubois, Naseem Amin, and C.Oma Kamlin
- Subjects
Hepatology - Published
- 2022
30. Mean-field theory of the three-level associative memory and its synthesis.
- Author
-
Peter Ott
- Published
- 1995
- Full Text
- View/download PDF
31. Versicherungsbilanzen: Rechnungslegung nach HGB und IFRS
- Author
-
Werner Rockel, Elmar Helten, Peter Ott, Roman Sauer
- Published
- 2012
32. The pathophysiology of Wilson's disease visualized: A human
- Author
-
Thomas Damgaard, Sandahl, Lars C, Gormsen, Kristoffer, Kjaergaard, Mikkel Holm, Vendelbo, Ditte Emilie, Munk, Ole Lajord, Munk, Dirk, Bender, Susanne, Keiding, Karina H, Vase, Kim, Frisch, Hendrik, Vilstrup, and Peter, Ott
- Subjects
Heterozygote ,Hepatolenticular Degeneration ,Positron Emission Tomography Computed Tomography ,Positron-Emission Tomography ,Humans - Abstract
Wilson's disease (WD) is a genetic disease with systemic accumulation of copper that leads to symptoms from the liver and brain. However, the underlying defects in copper transport kinetics are only partly understood. We sought to quantify hepatic copper turnover in patients with WD compared with heterozygote and control subjects using PET with copper-64 (Nine patients with WD, 5 healthy heterozygote subjects, and 8 healthy controls were injected with an i.v. bolus of
- Published
- 2021
33. Low cerebral energy metabolism in hepatic encephalopathy reflects low neuronal energy demand. Role of ammonia-induced increased GABAergic tone
- Author
-
Michael Sørensen, Anne Byriel Walls, Gitte Dam, Lasse Kristoffer Bak, Jens Velde Andersen, Peter Ott, Hendrik Vilstrup, and Arne Schousboe
- Subjects
Neurons ,Hepatic Encephalopathy/etiology ,Glutamine ,Neurons/metabolism ,Biophysics ,Ammonia/metabolism ,Brain ,Cell Biology ,Biochemistry ,Hyperammonemia/metabolism ,Glutamine/metabolism ,Ammonia ,Hepatic Encephalopathy ,Brain/metabolism ,Humans ,Hyperammonemia ,Energy Metabolism ,Molecular Biology - Abstract
Hepatic encephalopathy (HE) is a frequent and devastating but generally reversible neuropsychiatric complication secondary to chronic and acute liver failure. During HE, brain energy metabolism is markedly reduced and it remains unclear whether this is due to external or internal energy supply limitations, or secondary to depressed neuronal cellular functions - and if so, which mechanisms that are in play. The extent of deteriorated cerebral function correlates to blood ammonia levels but the metabolic link to ammonia is not clear. Early studies suggested that high levels of ammonia inhibited key tricarboxylic acid (TCA) cycle enzymes thus limiting mitochondrial energy production and oxygen consumption; however, later studies by us and others showed that this is not the case in vivo. Here, based on a series of translational studies from our group, we advocate the view that the low cerebral energy metabolism of HE is likely to be caused by neuronal metabolic depression due to an elevated GABAergic tone rather than by restricted energy availability. The increased GABAergic tone seems to be secondary to synthesis of large amounts of glutamine in astrocytes for detoxification of ammonia with the glutamine acting as a precursor for elevated neuronal synthesis of vesicular GABA.
- Published
- 2022
34. Glutamate Dehydrogenase Is Important for Ammonia Fixation and Amino Acid Homeostasis in Brain During Hyperammonemia
- Author
-
Anne B. Walls, Helle S. Waagepetersen, Arne Schousboe, Caroline M. Voss, Lene Arildsen, Peter Ott, Hendrik Vilstrup, Jakob D. Nissen, and Pierre Maechler
- Subjects
0301 basic medicine ,hyperammonemia ,brain ,Neurosciences. Biological psychiatry. Neuropsychiatry ,glutamate ,pyruvate carboxylase (PC) ,03 medical and health sciences ,0302 clinical medicine ,Amino acid homeostasis ,Glutamine synthetase ,medicine ,ddc:612 ,Original Research ,Alanine ,Chemistry ,Glutamate dehydrogenase ,General Neuroscience ,Glutamate receptor ,glutamate dehydogenase ,Hyperammonemia ,Metabolism ,medicine.disease ,Glutamine ,030104 developmental biology ,Biochemistry ,glutamine ,alanine ,030217 neurology & neurosurgery ,RC321-571 ,Neuroscience - Abstract
Impaired liver function may lead to hyperammonemia and risk for hepatic encephalopathy. In brain, detoxification of ammonia is mediated mainly by glutamine synthetase (GS) in astrocytes. This requires a continuous de novo synthesis of glutamate, likely involving the action of both pyruvate carboxylase (PC) and glutamate dehydrogenase (GDH). An increased PC activity upon ammonia exposure and the importance of PC activity for glutamine synthesis has previously been demonstrated while the importance of GDH for generation of glutamate as precursor for glutamine synthesis has received little attention. We therefore investigated the functional importance of GDH for brain metabolism during hyperammonemia. To this end, brain slices were acutely isolated from transgenic CNS-specific GDH null or litter mate control mice and incubated in aCSF containing [U-13C]glucose in the absence or presence of 1 or 5 mM ammonia. In another set of experiments, brain slices were incubated in aCSF containing 1 or 5 mM 15N-labeled NH4Cl and 5 mM unlabeled glucose. Tissue extracts were analyzed for isotopic labeling in metabolites and for total amounts of amino acids. As a novel finding, we reveal a central importance of GDH function for cerebral ammonia fixation and as a prerequisite for de novo synthesis of glutamate and glutamine during hyperammonemia. Moreover, we demonstrated an important role of the concerted action of GDH and alanine aminotransferase in hyperammonemia; the products alanine and α-ketoglutarate serve as an ammonia sink and as a substrate for ammonia fixation via GDH, respectively. The role of this mechanism in human hyperammonemic states remains to be studied.
- Published
- 2021
- Full Text
- View/download PDF
35. Efficacy and safety of ALXN1840 versus standard of care in Wilson disease: primary results from an ongoing phase 3, randomized, controlled, rater-blinded trial
- Author
-
Karl Heinz Weiss, Michael Schilsky, Anna Czlonkowska, Fred Askari, Aftab Ala, Peter Ferenci, Peter Ott, Dzhamal Abdurakhmanov, Ferenc Szalay, Piotr Socha, Norikazu Shimizu, Jeff Bronstein, Danny Bega, Sihoun Hahn, Eugene Swenson, Yi Chen, and Aurelia Poujois
- Subjects
Hepatology - Published
- 2022
36. Defining the boundaries for 'stability' in Wilson disease patients on maintenance chelation therapy: lessons from the CHELATE trial
- Author
-
C.Oma Kamlin, Michael Schilsky, Peter Ott, Karl Heinz Weiss, Massimo Giovanni Zuin, Aurelia Poujois, Aftab Ala, and Koenraad D’Hollander
- Subjects
Hepatology - Published
- 2022
37. Celebration of Professor Bernhard Weigand on his 60th birthday
- Author
-
Xu Chu, Guang Yang, Alexandros Terzis, Visakh Vaikuntanathan, Wenkang Wang, Zhouhang Li, Grazia Lamanna, Stephanie Fest-Santini, Maurizio Santini, Gianpietro Elvio Cossali, Phillip Ligrani, Bassam A. Younis, Michael Crawford, Peter Ott, Jürgen Köhler, Christian Rohde, Claus-Dieter Munz, Rainer Helmig, and Tianshou Zhao
- Subjects
Fluid Flow and Transfer Processes ,Mechanical Engineering ,Condensed Matter Physics - Published
- 2022
38. Cognitive impairment in stable Wilson disease across phenotype
- Author
-
Frederik Teicher Kirk, Hendrik Vilstrup, Thomas Damgaard Sandahl, Ditte Emilie Munk, Mette Munk Lauridsen, Peter Ott, Tea Lund Laursen, and Henning Grønbæk
- Subjects
medicine.medical_specialty ,Neurology ,Urinary system ,Pilot Projects ,Disease ,Biochemistry ,Gastroenterology ,Excretion ,Cellular and Molecular Neuroscience ,Hepatolenticular Degeneration ,Internal medicine ,Medicine ,Humans ,Cognitive Dysfunction ,Cognitive impairment ,Wilson disease ,business.industry ,Neurological phenotype ,Cognition ,Phenotype ,Continuous reaction test ,Hepatic phenotype ,Cross-Sectional Studies ,Copper-Transporting ATPases ,Cohort ,Female ,Neurology (clinical) ,Cognitive function ,business ,Portosystemic encephalopathy test ,Copper - Abstract
Background: In Wilson disease (WD), mutations in the gene encoding the ATP7B copper transport protein causes accumulation of copper especially in liver and brain. WD typically presents with hepatic and/or neuropsychiatric symptoms. Impaired cognition is a well-described feature in patients neurological WD, while the reports on cognition in hepatic WD patients are fewer and less conclusive. We examined cognition in a cohort of WD patients with both phenotypes. Methods: In this cross-sectional pilot study, we investigated cognition in 28 stable Danish WD patients by portosystemic encephalopathy (PSE) and continuous reaction time (CRT) tests. Half of the patients were female and median age was 35.5 years (IQR 24.5). The phenotype was hepatic in 14 (50%), neurologic in 10 (36%) and mixed in 4 4 (14%). The duration of treatment was >2 year in all patients, and the condition stable as judged by urinary copper excretion, liver enzymes, and clinical assessment.Results: In total, 16 (57%) patients performed worse than normal in the PSE and/or CRT tests. The two tests correlated (rho=0.60, p=0.0007) with each other, but neither correlated with phenotype, MELD-, Child-Pugh score, 24h-U-Cu, or treatment type.Conclusion: Measurable cognitive impairment was present in more than half of the stable WD patients independent of phenotype. Thus, our data questions the existence of a purely hepatic phenotype.
- Published
- 2021
39. CFAR Detector for Compressed Sensing Radar Based on l1-norm Minimisation
- Author
-
Peter Ott and Dmitrii Kozlov
- Subjects
Computer science ,Real-time computing ,Detector ,020206 networking & telecommunications ,02 engineering and technology ,law.invention ,Constant false alarm rate ,Cfar detector ,Nonlinear system ,Compressed sensing ,law ,0202 electrical engineering, electronic engineering, information engineering ,020201 artificial intelligence & image processing ,Radar - Abstract
Rapidly developing Compressed Sensing theory looks promising for many practical applications, since it allows us to reconstruct K-sparce signals and to reduce some hardware requirements. In this work, we consider the problem of changing noise properties after recovering and its influence on the radar false alarm rate. Due to nonlinearity of the recovering algorithm there is no analytical solution allowing finding a noise distribution after the reconstruction. Therefore, by an empirical approach we come to a solution, where the well-known cell averaging constant false alarm rate detector can be used for a compressed sensing radar. We analyze its performance by simulation and test it with real radar data.
- Published
- 2021
40. A Cognitive FMCW Radar to Minimize a Sequence of Range-Doppler Measurements
- Author
-
Peter Ott, Marco Altmann, Christian Waldschmidt, Nicolaj C. Stache, and Dmitrii Kozlov
- Subjects
Sequence ,Computer science ,business.industry ,Deep learning ,Real-time computing ,Bandwidth (signal processing) ,020206 networking & telecommunications ,02 engineering and technology ,010501 environmental sciences ,01 natural sciences ,law.invention ,Continuous-wave radar ,law ,0202 electrical engineering, electronic engineering, information engineering ,Chirp ,Reinforcement learning ,ComputerSystemsOrganization_SPECIAL-PURPOSEANDAPPLICATION-BASEDSYSTEMS ,Artificial intelligence ,Radar ,business ,Energy (signal processing) ,0105 earth and related environmental sciences - Abstract
This paper proposes a cognitive radar setup to learn the minimal sequence of Range-Doppler measurements for accurate multi-target detection with adaptive parameters. This minimal measurement sequence is achieved by a novel reward definition in a Reinforcement Learning approach. Thus, the cognitive radar learns to optimize its measurement time and energy savings. Based on Range-Doppler maps, the Reinforcement Learning agent adapts the FMCW parameters like bandwidth, sweep time, chirp repetition time and number of chirps to optimize the recognition in a three-target scenario. The agent is trained using Proximal Policy Optimization (PPO) in a simulated radar environment.
- Published
- 2021
41. Experimental investigation of sequential narrow impingement channels for turbine cooling
- Author
-
Peter Ott, Marc Henze, Michele Gaffuri, and Shailendra Naik
- Subjects
Materials science ,Heat transfer coefficient ,Mechanics ,Heat Transfer ,Turbine ,Liquid Crystals ,Reduction (complexity) ,Experimental ,Liquid crystal ,Transition zone ,Heat transfer ,GTT ,Transient (oscillation) ,Cooling ,Gas Turbine ,Flow Measurement ,Communication channel - Abstract
Sequentially stacked impingement channels allow for a more effective use of the cooling fluid and can limit the heat transfer reduction due to the crossflow when the number of jets increases. In this paper, sequential impingement channels are experimentally investigated using the transient liquid crystal technique. Twelve configurations are tested: the baseline consists in a double rectangular channel with 5 jets per channel; other configurations feature different number of jets, variations of the jet-to-jet spacing and of the transition zone length, reduction of the cross-section in the transition zone and addition of a bypass between the channels. Results show that heat transfer coefficients (HTC) in the 2nd channel are similar to the 1st, and that the cross-section reduction in the transition zone allows for an increase of the HTC in this critical zone with only a moderate increase of pressure losses.
- Published
- 2021
42. Cardiac arrhythmia visualization in a virtual heart for electrophysiology education.
- Author
-
Dong Xing, Jerzy W. Rozenblit, Samantha Bernau, and Peter Ott
- Published
- 2014
43. XIV. Beschreibungen ausgewählter Fachsprachen I: deutsche Fachsprachen der Urproduktion und des Handwerks
- Author
-
Dieter Möhn, Jürgen Eichhoff, Reinhard Goltz, Gerhard Kettmann, Jürgen Meier, Wolfgang Kleiber, Rudolf Post, Heinrich J. Dingeldein, Roland Mulch, Ilpo Tapani Piirainen, Kurt Dröge, Sigrid Schwenk, Peter Ott, Hans Bickel, Hermann Niebaum, and Oskar Reichmann
- Published
- 2020
44. Two Kalman Models for Chirp-Sequence Radar Data Filtering of a Periodically Moving Hand for Conducting a Virtual Orchestra
- Author
-
Peter Ott, Dmitrii Kozlov, Morris Ohrnberger, and Lisa-Franziska Schafer
- Subjects
Continuous-wave radar ,Radar engineering details ,law ,Computer science ,Acoustics ,Chirp ,Kalman filter ,Filter (signal processing) ,Radar ,Signal ,law.invention ,Data modeling - Abstract
In this paper two Kalman filter models are presented to filter a signal of a FMCW radar sensor. The measurement object is a rhythmic hand movement of a conductor. From the radar signal we get the distance and velocity. The models are intended to correct the noisy signal for later analysis of frequency and phase so that the tempo and beat of the conductor can be estimated. We evaluate and compare the models with simulated and real data from a chirp-sequence radar sensor.
- Published
- 2020
45. Memory Traces Formed in Utero—Newborns’ Autonomic and Neuronal Responses to Prenatal Stimuli and the Maternal Voice
- Author
-
Schabus, Adelheid Lang, Peter Ott, Renata del Giudice, and Manuel
- Subjects
behavioral disciplines and activities ,reproductive and urinary physiology ,perinatal memory ,fetal learning ,fetus ,newborn ,maternal voice ,heart rate ,EEG ,speech–brain coupling - Abstract
In our pilot study, we exposed third-trimester fetuses, from week 34 of gestation onwards, twice daily to a maternal spoken nursery rhyme. Two and five weeks after birth, 34 newborns, who were either familiarized with rhyme stimulation in utero or stimulation naïve, were (re-)exposed to the familiar, as well as to a novel and unfamiliar, rhyme, both spoken with the maternal and an unfamiliar female voice. For the stimulation-naïve group, both rhymes were unfamiliar. During stimulus presentation, heart rate activity and high-density electroencephalography were collected and newborns’ responses during familiar and unfamiliar stimulation were analyzed. All newborns demonstrated stronger speech–brain coupling at 1 Hz during the presentation of the maternal voice vs. the unfamiliar female voice. Rhyme familiarity originating from prenatal exposure had no effect on speech–brain coupling in experimentally stimulated newborns. Furthermore, only stimulation-naïve newborns demonstrated an increase in heart rate during the presentation of the unfamiliar female voice. The results indicate prenatal familiarization to auditory speech and point to the specific significance of the maternal voice already in two- to five-week-old newborns.
- Published
- 2020
- Full Text
- View/download PDF
46. Recovery of Moderate Coronavirus Disease 2019 in a Liver Transplant Recipient on Continued Immunosuppression: A Case Report
- Author
-
Peter Ott, Steffen Leth, Søren Jensen-Fangel, Victor Dahl Mathiasen, and Stine Karlsen Oversoe
- Subjects
Pediatrics ,medicine.medical_treatment ,030230 surgery ,Liver transplantation ,SARS-CoV2, severe acute respiratory syndrome coronavirus 2 ,DNA, Deoxyribonucleic acid ,0302 clinical medicine ,Oxygen therapy ,Pandemic ,Medicine ,COVID-19, Coronavirus disease 2019 ,immunosuppression ,liver transplantation ,organ transplantation ,Immunosuppression ,Middle Aged ,TID, Ter in die (three times a day) ,EASL-ESCMID, The European Association for the Study of the Liver and the European Society of Clinical Microbiology and Infectious Diseases ,Female ,BID, Bis in die (twice a day) ,030211 gastroenterology & hepatology ,medicine.symptom ,Coronavirus Infections ,QD, Quaque die (one per day) ,Immunosuppressive Agents ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Pneumonia, Viral ,Pneumonia, Viral/immunology ,Article ,Malaise ,Betacoronavirus ,Coronavirus Infections/immunology ,Immunocompromised Host ,03 medical and health sciences ,Humans ,RNA, Ribonucleic acid ,Pandemics ,Transplantation ,SARS-CoV-2 ,business.industry ,COVID-19 ,Outbreak ,Tacrolimus ,Liver Transplantation ,hepatology ,SARS-CoV2 ,Immunosuppressive Agents/therapeutic use ,Surgery ,BMI, Body Mass Index ,PCR, Polymerase chain reaction ,business - Abstract
The global outbreak of severe acute respiratory syndrome coronavirus 2 has had an enormous impact on the world. It remains unclear to what extent liver transplant recipients should be considered at a higher risk of severe disease due to the limited data available. We describe a moderate course of COVID-19 in a patient who underwent a liver transplant two years earlier due to Budd-Chiari syndrome. The patient presented with malaise, headache, dry cough and fever for four days. Immunosuppressive therapy with tacrolimus and mycophenolate mofetil was continued throughout the course of infection, oxygen therapy was given for a single night and the patient gradually recovered with supportive care only. With this case report, we demonstrate that liver transplantation and immunosuppression is not necessarily associated with severe COVID-19 disease and emphasize that more information on this matter is urgently required. Withdrawal of immunosuppressive therapy could be associated with a higher mortality., Highlights • There is sparse evidence about the impact of SARS-CoV2 on liver transplant recipients. • Limited data suggest a high early mortality in these patients. • Withdrawal of immunosuppressive therapy could be associated with poorer outcomes. • Each case must be evaluated and managed carefully by experts.
- Published
- 2020
- Full Text
- View/download PDF
47. Compensated Cirrhosis and 20 mm Hg: A Point of No Return?
- Author
-
Enric Reverter and Peter Ott
- Subjects
Liver Cirrhosis ,medicine.medical_specialty ,Point of no return ,Cirrhosis ,Hepatology ,business.industry ,General surgery ,Portal venous pressure ,Gastroenterology ,MEDLINE ,medicine.disease ,Portal Pressure ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Hypertension, Portal ,medicine ,Humans ,030211 gastroenterology & hepatology ,business - Abstract
This editorial comments on the findings from the study by Jindal et al. recently published in The American Journal of Gastroenterology. Weaknesses and strengths of the study are presented, and potential therapeutic strategies for compensated cirrhotic patients with an HVPG ≥20 mm Hg are proposed.
- Published
- 2020
48. A 160-GHz radar sniffer probe for honey bee detection
- Author
-
Martin Geiger, Thomas Walter, Peter Ott, Torsten Bandel, Philipp Hugler, Thomas Galler, Wolf-Henning Rech, and Christian Waldschmidt
- Subjects
Materials science ,Acoustics ,MMIC-to-waveguide transition ,Physics::Optics ,Dielectric ,law.invention ,Front and back ends ,Millimeter wave communication systems ,law ,Lens antennas ,DDC 620 / Engineering & allied operations ,Radar ,Monolithic microwave integrated circuit ,Dielectric waveguide ,Wave guides ,Millimeter wave ,Millimeterwelle ,Radar sniffer probe ,Chirp-sequence radar ,Intermediate frequency ,Hohlleiter ,Lens antenna ,MMIC ,Extremely high frequency ,Dielectric loss ,Dielectrics ,Antenna (radio) ,ddc:620 ,Linsenantenne ,Flexible radar sensor - Abstract
The use of radar systems is limited in some applications by spatial constraints or special thermal and environmental conditions. The spatial separation of the sensitive electronics and the more robust antenna by a ���exible connection therefore opens up new applications. A 160-GHz radar system with a mechanically ���exible front end ful���lling these requirements is proposed in this paper. The ���exible front end is an extremely low loss dielectric waveguide feeding a dielectric elliptical lens antenna (28 dBi gain). The dielectric waveguide has dielectric losses of 4.5 dB/m at 160 GHz and is very ���exible, allowing bending radii of down to 1.5 cm with negligible losses. The dielectric waveguide is fed by a 160-GHz radar monolithic microwave integrated circuit (MMIC), which allows bandwidths of up to 20 GHz for a high range resolution. The transition between MMIC and dielectric waveguide is realized with a rectangular-waveguide interface. The radar back end consists of a phased-locked loop (PLL) with standard components, an intermediate frequency (IF) signal conditioning part, and a Xilinx Zynq 7030 System-On-Module (SOM) with an FPGA and an ARM-based processor. The sampled signal is processed directly on the FPGA with a 2D Fourier transform and is available as a UDP stream with an update rate of up to 15 Hz. In addition, a camera image is taken for each radar measurement. The presented system is used to detect and measure the ���ight behavior of honey bees. The electronics are housed in a building whereas the ���exible dielectric waveguide allows the antenna to be placed anywhere around the beehive, where it is exposed to environmental conditions., publishedVersion
- Published
- 2020
49. Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [64Cu]copper PET/CT
- Author
-
Ole Lajord Munk, Peter Ott, Susanne Keiding, Kim Frisch, Karina H. Vase, Kristoffer Kjærgaard, Hendrik Vilstrup, Thomas Damgaard Sandahl, and Lars C. Gormsen
- Subjects
lcsh:Medical physics. Medical radiology. Nuclear medicine ,Biodistribution ,lcsh:R895-920 ,Effective dose (radiation) ,030218 nuclear medicine & medical imaging ,Analytical Chemistry ,Excretion ,03 medical and health sciences ,0302 clinical medicine ,Oral administration ,Dosimetry ,medicine ,Pharmacology (medical) ,Radiology, Nuclear Medicine and imaging ,Pharmacology ,PET-CT ,Gastrointestinal tract ,medicine.diagnostic_test ,business.industry ,lcsh:RM1-950 ,Kinetics ,64Cu ,lcsh:Therapeutics. Pharmacology ,Positron emission tomography ,030220 oncology & carcinogenesis ,Nuclear medicine ,business ,Copper - Abstract
Purpose Copper is essential for enzymatic processes throughout the body. [64Cu]copper (64Cu) positron emission tomography (PET) has been investigated as a diagnostic tool for certain malignancies, but has not yet been used to study copper homeostasis in humans. In this study, we determined the hepatic removal kinetics, biodistribution and radiation dosimetry of 64Cu in healthy humans by both intravenous and oral administration. Methods Six healthy participants underwent PET/CT studies with intravenous or oral administration of 64Cu. A 90 min dynamic PET/CT scan of the liver was followed by three whole-body PET/CT scans at 1.5, 6, and 20 h after tracer administration. PET data were used for estimation of hepatic kinetics, biodistribution, effective doses, and absorbed doses for critical organs. Results After intravenous administration, 64Cu uptake was highest in the liver, intestinal walls and pancreas; the gender-averaged effective dose was 62 ± 5 μSv/MBq (mean ± SD). After oral administration, 64Cu was almost exclusively taken up by the liver while leaving a significant amount of radiotracer in the gastrointestinal lumen, resulting in an effective dose of 113 ± 1 μSv/MBq. Excretion of 64Cu in urine and faeces after intravenous administration was negligible. Hepatic removal kinetics showed that the clearance of 64Cu from blood was 0.10 ± 0.02 mL blood/min/mL liver tissue, and the rate constant for excretion into bile or blood was 0.003 ± 0.002 min− 1. Conclusion 64Cu biodistribution and radiation dosimetry are influenced by the manner of tracer administration with high uptake by the liver, intestinal walls, and pancreas after intravenous administration, while after oral administration, 64Cu is rapidly absorbed from the gastrointestinal tract and deposited primarily in the liver. Administration of 50 MBq 64Cu yielded images of high quality for both administration forms with radiation doses of approximately 3.1 and 5.7 mSv, respectively, allowing for sequential studies in humans. Trial registration number EudraCT no. 2016–001975-59. Registration date: 19/09/2016.
- Published
- 2020
50. Soft Iterative Method with Adaptive Thresholding for Reconstruction of Radar Scenes
- Author
-
Otmar Loffeld, Marco Altmann, Dmitrii Kozlov, and Peter Ott
- Subjects
020301 aerospace & aeronautics ,Computational complexity theory ,Computer science ,Iterative method ,020206 networking & telecommunications ,02 engineering and technology ,Data rate ,Thresholding ,law.invention ,Reduction (complexity) ,Compressed sensing ,0203 mechanical engineering ,law ,0202 electrical engineering, electronic engineering, information engineering ,Radar ,Algorithm ,Energy (signal processing) - Abstract
A proper use of the advances of compressed sensing (CS) theory in radar systems may lead to data rate reduction, energy saving and measuring improvement. Using, e.g., randomly placed chirps and CS reconstruction algorithms, the velocity unambiguously measured by FMCW-Radars can be increased. In this paper, we propose to use the Soft Iterative Method with Adaptive Thresholding (soft-IMAT) for the reconstruction of the radar scene. Its performance is analyzed in different scenarios and compared with the original IMAT with respect to detection probability and computational complexity. A modified soft-IMAT is proposed in order to reduce the computational overhead caused by the soft-based decision.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.